
Avatrombopag NEW
Price | $59 | $123 | $197 |
Package | 1mg | 5mg | 10mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-04-27 |
Product Details
Product Name: Avatrombopag | CAS No.: 570406-98-3 |
Purity: 99.41% | Supply Ability: 10g |
Release date: 2025/04/27 |
Product Introduction
Bioactivity
Name | Avatrombopag |
Description | Avatrombopag (YM477) is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production. |
In vivo | Avatrombopag is treatment of thrombocytopenia in patients with CLD who are scheduled to undergo a procedure[1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : < 1 mg/mL (insoluble or slightly soluble) |
Keywords | YM-477 | YM 477 | TPO | ThrombopoietinReceptor | Thrombopoietin Receptor | proliferation | phosphorylation | NOD/SCID | mimic | megakaryocytopoiesis | megakaryocytes | Inhibitor | inhibit | E-5501 | E 5501 | Avatrombopag | AKR501 | AKR 501 |
Inhibitors Related | Dabigatran Etexilate Mesylate | (S)-(+)-Ibuprofen | Edoxaban | AEBSF hydrochloride | Heparin sodium salt | Thrombin (MW 37kDa) | Edoxaban Tosylate Monohydrate | Menadione | Ozagrel | Argatroban | Eltrombopag Olamine | p-Hydroxycinnamic acid |
Related Compound Libraries | Failed Clinical Trials Compound Library | Bioactive Compound Library | ReFRAME Related Library | EMA Approved Drug Library | Protease Inhibitor Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/10mg |
VIP2Y
|
ShenZhen H&D Pharmaceutical Technology Co., LTD
|
2024-04-01 | |
$0.00/1kg |
VIP3Y
|
Nanjing Kaitian Chemical Co., LTD
|
2023-02-10 | |
$0.00/25kg |
VIP6Y
|
Zison Pharmaceutical (Shandong) Co., Ltd.
|
2023-01-05 | |
$1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-08-04 | |
$1.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-02-14 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY